Kleita Michaelidou
Overview
Explore the profile of Kleita Michaelidou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papadaki M, Papadaki E, Chatziavraam S, Aggouraki D, Michaelidou K, Fotsitzoudis C, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272785
The Fas/Fas ligand (FasL) system is a major apoptosis-regulating pathway with a key role in tumor immune surveillance and metastasis. The expression of Fas/FasL on mammary tumor tissues holds prognostic...
2.
Michaelidou K, Karniadakis I, Pantelaion V, Koutoulaki C, Boukla E, Folinas K, et al.
Expert Rev Mol Diagn
. 2024 Jan;
24(1-2):89-98.
PMID: 38193169
Background: Limited information exists on epidermal growth factor receptor molecular epidemiology in Greece. Next-generation sequencing (NGS) is the recommended method for genotyping in NSCLC. The Idylla Biocartis platform is a...
3.
Psilopatis I, Karniadakis I, Danos K, Vrettou K, Michaelidou K, Mavridis K, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613532
Lung cancer (LC) is the leading cause of cancer death in the United States. Erythropoietin-producing hepatocellular receptors (EPHs) comprise the largest receptor tyrosine kinases (RTKs) family in mammals. EPHs along...
4.
Mavridis K, Ilias A, Papapostolou K, Varikou K, Michaelidou K, Tsagkarakou A, et al.
Pest Manag Sci
. 2022 Dec;
79(4):1615-1622.
PMID: 36562265
Background: Insecticide resistance has emerged in various western flower thrips (WFT) populations across the world, threatening the efficiency of chemical control applications. Elucidation of insecticide resistance mechanisms at the molecular...
5.
Monastirioti A, Papadaki C, Kalapanida D, Rounis K, Michaelidou K, Papadaki M, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230658
Since circulating microRNAs (miRNAs) are involved in the modulation of the immune response, they are tested as liquid biopsy-based biomarkers in patients with NSCLC treated with immunotherapy. We analyzed the...
6.
Tzagournissakis M, Foukarakis E, Samonakis D, Tsilimbaris M, Michaelidou K, Mathioudakis L, et al.
Neurol Genet
. 2022 Sep;
8(5):e200013.
PMID: 36101541
Background And Objectives: Our goal was to study hereditary transthyretin-related amyloidosis (hATTR) in Crete, Greece. Methods: We aimed at ascertaining all hATTR cases in Crete, an island of 0.62 million...
7.
Mavridis K, Papapostolou K, Ilias A, Michaelidou K, Stavrakaki M, Roditakis E, et al.
Pest Manag Sci
. 2022 Sep;
78(11):4994-5001.
PMID: 36054028
Background: Insecticide resistance has developed in several populations of the whitefly Bemisia tabaci worldwide and threatens to compromise the efficacy of chemical control. The molecular mechanisms underpinning resistance have been...
8.
Papadaki M, Monastirioti A, Apostolopoulou C, Aggouraki D, Papadaki C, Michaelidou K, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205801
TLR4 and pSTAT3 are key players in cancer inflammation and immune evasion; however, their role in the peripheral blood (PB) is largely unexplored. Herein we evaluated their expression in the...
9.
Naoumi N, Michaelidou K, Papadakis G, Simaiaki A, Fernandez R, Calero M, et al.
ACS Sens
. 2022 Jan;
7(2):495-503.
PMID: 35073481
Regular screening of point mutations is of importance to cancer management and treatment selection. Although techniques like next-generation sequencing and digital polymerase chain reaction (PCR) are available, these are lacking...
10.
Zaganas I, Vorgia P, Spilioti M, Mathioudakis L, Raissaki M, Ilia S, et al.
Epilepsy Behav Rep
. 2021 Sep;
16:100477.
PMID: 34568804
We describe a cohort of 10 unrelated Greek patients (4 females, 6 males; median age 6.5 years, range 2-18 years) with heterogeneous epilepsy syndromes with a genetic basis. In these...